Company: BIAF
Filing Date: 2025-11-14
Form Type: 8-K
Source: 0001493152-25-022604
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-11-14
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item
2.02. Results of Operation and Financial Condition.

On
November 14, 2025, bioAffinity Technologies, Inc., a Delaware corporation (the “ Company”), issued a press release that included
financial information for its quarter ended September 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current
Report on Form 8-K.

The
information in this Item 2.02 and in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed
to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this
Item 2.02 and in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K shall not be incorporated by reference
into any filing with the U. S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless
of any general incorporation language in such filing.